Assessment of Efficacy of Pharmacotherapy for Ventricular Tachycardia

Heart Lung and Circulation

Volumn 16, Issue 3, 2007, Pages 170-175

  Cooper, Mark J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Antiarrhythmic drug therapy; Arrhythmia; Ventricular tachycardia

Indexed keywords

2 DIETHYLAMINOETHANOL; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CINCHONA EXTRACT; FLECAINIDE; LIDOCAINE; NEW DRUG; QUINIDINE; QUINIDINE SULFATE; QUININE DERIVATIVE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL;

ARRHYTHMOGENESIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; CLINICAL TRIAL; DEFIBRILLATOR; DRUG CONTRAINDICATION; DRUG EFFICACY; HEART ARRHYTHMIA; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOLTER MONITORING; HUMAN; NONHUMAN; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; UNSPECIFIED SIDE EFFECT;

ANTI-ARRHYTHMIA AGENTS; AUSTRALIA; BIOMEDICAL RESEARCH; DEFIBRILLATORS, IMPLANTABLE; HISTORY, 20TH CENTURY; HOSPITAL ADMINISTRATION; HUMANS; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 34248594227     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.03.006     Document Type: Article

References (65)

1. Gold H. Treatment of cardiac arrhythmias. Med Clin N Am 24 (1940) 577-593
2. Lewis T. Single and successive extrasystoles. Lancet 1 (1909) 382-385
3. MacKenzie J. The study of the pulse, arterial, venous and hepatic, and of the movements of the heart (1902), Macmillan and Co., London
4. Wenckebach KF. Arrhythmia of the heart [Snowball T, Trans.]. Edinburgh and London: Wm Green and Sons; 1904.
5. Robinson G.C. A study with the electrocardiograph of the mode of death of the human heart. J Exp Med 16 (1912) 291-302
6. Robinson G.C., and Bredeck J.F. Ventricular fibrillation in man with cardiac recovery. Arch Int Med 20 (1917) 725-738
7. Robinson G.C., and Hermann G.R. Paroxysmal tachycardia of ventricular origin and its relation to coronary occlusion. Heart 8 (1921) 59
8. Williams C., and Ellis L.B. Ventricular tachycardia: an analysis of 36 cases. Arch Int Med 71 (1943) 137-156
9. Hermann G.R., and Hejtmancik M.R. A clinical and electrocardiographic study of paroxysmal ventricular tachycardia and its management. Ann Int Med 28 (1948) 989-997
10. Armbrust Jr. C.A., and Levine S.A. Paroxysmal ventricular tachycardia: a study of 107 cases. Circulation 1 (1950) 28-40
11. Wolferth C.C., and McMillan T.M. Paroxysmal ventricular tachycardia. Arch Int Med 31 (1923) 184-199
12. Mays A.T. Ventricular tachycardia of unusually long duration (seventy seven days). Am Heart J 23 (1942) 119-127
13. Frey W. Weitere erfahrungen mit chinidin bei absoluter herzunregelmassigkeit. Berl Klin Wchnschr 55 (1918) 849-853
14. Wenckebach K.F. Cinchona derivatives in the treatment of heart disorders. JAMA 81 (1923) 472-474
15. Willius F.A., and Keys T.E. A remarkably early reference to the use of cinchona in cardiac arrhythmias. Proc Staff Meetings Mayo Clinics 17 (1942) 294-296
16. Scott R.W. Observations on a case of ventricular tachycardia with retrograde conduction. Heart 9 (1921) 297
17. Levine S.A., and Stevens W.B. The therapeutic value of quinidine in coronary thrombosis complicated by ventricular tachycardia. Am Heart J 3 (1928) 253-259
18. Viko L.E., Marvin H.M., and White P.D. A clinical report on the use of quinidin sulphate. Arch Int Med 31 (1923) 345-363
19. Levy R.L. The clinical toxicology of quinidin (abstr). JAMA 78 (1922) 1919
20. Oppenheimer B.S., and Mann H. Results with quinidin in heart disease (abstr). JAMA 78 (1922) 1758
21. Lewis T., Drury A.N., Wedd A.M., and Iliescu C.C. Observations upon the actions of certain drugs upon fibrillation of the auricles. Heart 9 (1922) 207
22. Parkinson J., and Campbell M. Quinidine treatment of auricular fibrillation. Q J Med 22 (1929) 281-303
23. Flaker G.C., Blackshear J.L., McBride R., Kronmal R.A., Halperin J.L., and Hart R.G. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 20 (1992) 527
24. Kochman M., and Daels F. Wirking des kokains auf das warmbluterhez unter besonderer berucksichtiging der extrasystole. Arch Int Pharmacodyn 18 (1908) 41
25. Mautz F.R. Reduction of cardiac irritability by the epicardial and systemic administration of drugs as a protection in cardiac surgery. J Thorac Surg 5 (1936) 612-628
26. Burstein C.L., Marangoni B.A., De Graff A.C., and Rovenstine E.A. Laboratory studies on the prophylaxis and treatment of ventricular fibrillation induced by epinephrine during cyclopropane anaesthesia. Anesthesiology 1 (1940) 167-186
27. Burstein C.L. Treatment of acute arrhythmias during anesthesia by intravenous procaine. Anesthesiology 7 (1946) 113-121
28. Mark L.C., Berlin I., Kayden H.J., Rovenstine E.A., Steel J.M., and Brodie B.B. The action of procaine amide (N-[2-diethylamino-ethyl]-p-aminobenzamid) on ventricular arrhythmias (abstr). J Pharmacol Exp Therap 98 (1950) 21-22
29. Van Dongen K. The action of xylocaine on fibrillation of the heart. Arch Int Pharmacodyn 96 (1953) 45-48
30. Carden M.L., and Steinhaus J.E. Lidocaine in cardiac resuscitation from ventricular fibrillation. Circ Res 4 (1956) 680-683
31. Nayler W.G. The cellular basis for antiarrhythmic therapy. In: Krikler D.M., and Goodwin J.F. (Eds). Cardiac arrhythmias: the modern electrophysiological approach (1975), WB Saunders, London 208-222
32. Patterson E., Scherlag B.J., and Lazzara R. Mechanism of prevention of sudden death by nadolol: differential actions on arrhythmia triggers and substrate after myocardial infarction in the dog. J Am Coll Cardiol 8 (1986) 1365-1372
33. Brown K.W.G., MacMillan R.L., Forbath N., Mel'Grano F., and Scott J.W. Coronary unit: an intensive care centre for acute myocardial infarction. Lancet 2 (1963) 349-352
34. Day H.W. An intensive coronary care area. Dis Chest 44 (1963) 423-427
35. Julian D.G., Valentine P.A., and Miller G.G. Disturbances of rate, rhythm and conduction in acute myocardial infarction: a prospective study of 100 consecutive patients with the aid of electrocardiographic monitoring. Am J Med 37 (1964) 915-927
36. Goble A.J., Sloman G., and Robinson J.S. Mortality reduction in a coronary care unit. Br Med J 1 (1966) 1005-1009
37. Lown B., Fakhro A.M., Hood Jr. W.B., and Thorn G.W. The coronary care unit: new perspectives and directions. JAMA 199 (1967) 188-198
38. Lown B., Amarasingham R., and Newman J. New method of terminating cardiac arrhythmias: use of synchronised capacitor discharge. JAMA 182 (1962) 548-555
39. Bjerkelund C.J. The effect of long-term treatment with dicoumarol in myocardial infarction. A controlled clinical study. Acta Med Scand 330 suppl. (1957) 13-21
40. Liberthson R.R., Nagel E.L., Hirschman J.C., and Nussenfeld S.R. Prehospital ventricular defibrillation: prognosis and follow-up course. N Engl J Med 291 (1974) 317-321
41. Adelson L., and Hoffman W. Sudden death from coronary disease. JAMA 176 (1961) 131-138
42. Friedman M., Mainwaring J.H., Rosenman R.H., Donlon G., Ortega P., and Grube S.M. Instantaneous and sudden deaths: clinical and pathological differentiation in coronary artery disease. JAMA 225 (1973) 1319-1328
43. Baum R.S., Alvarez III H., and Cobb L.A. Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation 50 (1974) 1231-1235
44. Wu D., Wyndham C.R., Denes P., Amat-y-Leon F., Miller R.H., Dhingra R.C., and Rosen K.M. Chronic electrophysiological study in patients with recurrent paroxysmal tachycardia: a new method for developing successful oral antiarrhythmic therapy. In: Kulbertus H.C. (Ed). Reentrant arrhythmias: mechanisms and treatment (1976), University Park Press, Baltimore 294-311
45. Denes P., Wu D., Dhingra R.C., Amat-y-Leon F., Wyndham C., Mautner R.K., and Rosen K.M. Electrophysiological studies in patients with chronic recurrent ventricular tachycardia. Circulation 54 (1976) 229-236
46. Doherty J.V., Kienzle M.G., Waxman H.L., Buxton A.E., Marchlinski F.E., and Josephson M.E. Programmed ventricular stimulation at a second right ventricular site: an analysis of 100 patients with special reference to sensitivity, specificity and characteristics of patients with induced ventricular tachycardia. Am J Cardiol 52 (1983) 1184-1189
47. Livelli F.D., Bigger J.T., Reiffel J.A., Gang E.S., Patton J.N., Noethling P.M., Rolnitzky L.M., and Gliklich J.I. Response to programmed ventricular stimulation: sensitivity, specificity and relation to heart disease. Am J Cardiol 50 (1982) 452-458
48. Mason J.W., and Winkle R.A. Accuracy of the ventricular tachycardia induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs. N Engl J Med 303 (1980) 1073-1077
49. Ruskin J.N., DiMarco J., and Garan H. Out-of-hospital cardiac arrest: electrophysiologic observations and selections of long-term antiarrhythmic therapy. N Engl J Med 303 (1980) 607-613
50. Horowitz L.N., Josephson M.E., Farshidi A., Spielman S.R., Michelson E.L., and Greenspan A.M. Recurrent sustained ventricular tachycardia. 3. Role of the electrophysiologic study in the selection of antiarrhythmic regimens. Circulation 58 (1978) 986-997
51. Brugada P., Lemery R., Talajic M., Della Bella P., and Wellens H.J.J. Treatment of patients with ventricular tachycardia or ventricular fibrillation: first lessons from the "parallel study. In: Brugada P., and Wellens H.J.J. (Eds). Cardiac arrhythmias: where to go from here? (1987), Futura, Mt Kisco, New York 457-470
52. Estes III N.A.M., Garan H., McGovern B., and Ruskin J.N. Influence of drive cycle length during programmed stimulation on induction of ventricular arrhythmias: analysis of 403 patients. Am J Cardiol 57 (1986) 108-112
53. Herre J.M., Mann D.E., Luck J.C., Magro S.A., Figali S., Breen T., and Wyndham C.R.C. Effect of increased current, multiple pacing sites and number of extrastimuli on induction of ventricular tachycardia. Am J Cardiol 57 (1986) 102-107
54. Lown B., and Graboys T.B. Management of patients with malignant ventricular arrhythmias. Am J Cardiol 39 (1977) 910-919
55. Podrid P.J., Lown B., Graboys T.B., and Lampert S. Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs. Circulation 73 suppl. II (1986) II-81-II-91
56. Gottlieb C., and Josephson M.E. The preference of programmed stimulation-guided therapy for sustained ventricular arrhythmias. In: Brugada P., and Wellens H.J.J. (Eds). Cardiac arrhythmias: where to go from here? (1987), Futura, Mt Kisco, New York 421-434
57. The Cardiac Arrhythmia Suppression Trial (CAST) investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
58. Denniss A.R., Richards D.A., Cody D., Russell P.A., Young A.A., Cooper M.J., Ross D.L., and Uther J.B. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 74 (1986) 731-745
59. Cooper M.J., Hunt L.J., Palmer K.J., Denniss A.R., Richards D.A., Uther J.B., and Ross D.L. Quantitation of day to day variability in mode of induction of ventricular tachyarrhythmias by programmed stimulation. J Am Coll Cardiol 11 (1988) 101-108
60. Cooper M.J., Hunt L.J., Richards D.A., Denniss A.R., Uther J.B., and Ross D.L. Effect of repetition of extrastimuli on sensitivity and reproducibility of mode of induction of ventricular tachycardia by programmed stimulation. J Am Coll Cardiol 11 (1988) 1260-1267
61. Cooper M.J., Koo C.C., Skinner M.P., Mortensen P.T., Hunt L.J., Richards D.A., Uther J.B., and Ross D.L. Comparison of immediate versus day to day variability of ventricular tachycardia induction by programmed stimulation. J Am Coll Cardiol 13 (1989) 1599-1607
62. Cooper M.J., Hunt L.J., Richards D.A., Uther J.B., and Ross D.L. Antiarrhythmic drugs retard rather than suppress induction of ventricular tachycardia. Circulation 76 suppl. IV (1987) IV-510
63. Cooper M.J., Hunt L.J., Denniss A.R., Palmer K.J., Richards D.A., Uther J.B., and Ross D.L. Prediction of proarrhythmic drug effects at electrophysiologic study for ventricular tachycardia. Circulation 74 suppl. II (1986) II-482
64. Kovoor P., Eipper V.E., Byth K., Cooper M.J., Uther J.B., and Ross D.L. Comparison of sotalol with amiodarone for long term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease. Eur Heart J 20 (1999) 364-374
65. Kovoor P., Yung A., Byth K., Eipper V.E., Uther J.F.B., Cooper M.J., and Ross D.L. Comparison of long term efficacy of implantable defibrillator and sotalol in documented spontaneous ventricular tachyarrhythmias secondary to coronary artery disease. Aust NZ J Med 29 (1999) 331-341